PORTENT is now accepting applications for 2025-26 Innovation Award Opportunity!
PORTENT is focused on supporting development, clinical validation, commercialization, and deployment of point-of-care technologies for nutrition, infection, and cancer. Part of the POCTRN+ network, PORTENT is supported by the National Institutes of Health.
Specific criteria for awards:
-
Proposals must show direct responsiveness to our Annual Needs Assessment Consensus.
-
Projects must identify an intended “setting of use” where their technology could have the greatest impact.
-
Projects must be at least at the TRL stage 3-5.
-
Proposals must identify specific milestones and describe how a successful outcome could advance the technology towards translational outcome.
-
Projects must identify the key challenge(s) to advancement and implementation of their technology.
-
Include details on how the PORTENT Clinical Network, PORTENT Knowledge Transfer workshops and Lab-to-Market Accelerator can help address some of the key challenges.
Award Opportunity details:
- Total funds available: Approximately $500,000 USD
- Project budget: Between $50,000 and $100,000 USD
- Project duration: 12-months
- Application deadline: June 6, 2025
2025 Award priorities:
Chronic disease, infectious disease, and disease prevention, and specifically include, but are not limited to:
-
Nutrition: Technologies that support the screening, prevention, and diagnosis of nutritional problems.
-
Infection: Multiplexed screening/diagnostic assays for infections such as those diagnosing HIV and co-infections, acute febrile illness, neglected tropical diseases, and/or mosquito borne illnesses (e.g. Malaria, Dengue, Chikungunya).
-
Cancer: Technologies that broaden cancer screening, diagnosis, and screening to community and clinic level.
-
Within these focus areas, proposals with alignment with Digital Health, AI & Connectivity and Wellness solutions are also encouraged.
|